Liver and Extrahepatic Cell-Selective Nucleic Acid Delivery Based on LNPs Using Novel Ionizable Lipids
Thu, Oct 29
|
04:30 PM - 04:45 PM
Fairfax
Session details:
- Safety and efficacy evaluation of our proprietary ionizable lipids in clinical trials and non-human primate studies
- In vivo immune cells delivery by active and passive targeting strategies using our ionizable lipids
- LNPs for ex vivo RNA and DNA transfection into human primary T cells, HSC and NK cells
